Clinical Research Directory

Browse clinical research sites, groups, and studies.

Sites Groups Studies

Back to Studies

RECRUITING

NCT06456489

PHASE3

Pulse Steroid Injection in Refractory Rheumatoid Arthritis

Sponsor: Sohag University

View on ClinicalTrials.gov

Summary

Remission or low disease activity in active rheumatoid arthritis

Official title: Revealing the Potential of Intravenous Pulse Steroid Therapy; Impressive Results in Attaining Remission or Low Disease Activity in Refractory Rheumatoid Arthritis

Key Details

Gender

All

Age Range

20 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

268

Start Date

2024-05-01

Completion Date

2024-12-31

Last Updated

2024-06-13

Healthy Volunteers

Conditions

Active Rheumatoid Arthritis

Interventions

DRUG

Solumedrol

125 mg methylprednisolone intravenous pulse on 2 consecutive days

Locations (1)

Al-Azhar Univrsity

Cairo, Egypt